No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
UBS Sticks to Their Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)
Why Elders, KMD, Lovisa, and Telix Shares Are Dropping Today
Telix Pharmaceuticals Secures License to Cancer Treatments in Germany
Express News | Telix Adss Commence Trading on Nasdaq
12 Non-bank ASX 200 Shares Smashing New 52-week Highs Today
U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk
No Data